IL106326A - Analogs of parathyroid hormone, their production and pharmaceutical compositions containing them - Google Patents

Analogs of parathyroid hormone, their production and pharmaceutical compositions containing them

Info

Publication number
IL106326A
IL106326A IL106326A IL10632693A IL106326A IL 106326 A IL106326 A IL 106326A IL 106326 A IL106326 A IL 106326A IL 10632693 A IL10632693 A IL 10632693A IL 106326 A IL106326 A IL 106326A
Authority
IL
Israel
Prior art keywords
analogs
production
pharmaceutical compositions
compositions containing
parathyroid hormone
Prior art date
Application number
IL106326A
Other languages
English (en)
Other versions
IL106326A0 (en
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929215009A external-priority patent/GB9215009D0/en
Priority claimed from GB929226415A external-priority patent/GB9226415D0/en
Priority claimed from GB929226859A external-priority patent/GB9226859D0/en
Priority claimed from GB929226861A external-priority patent/GB9226861D0/en
Priority claimed from GB939301692A external-priority patent/GB9301692D0/en
Priority claimed from GB939301691A external-priority patent/GB9301691D0/en
Priority claimed from GB939307673A external-priority patent/GB9307673D0/en
Priority claimed from GB939308033A external-priority patent/GB9308033D0/en
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of IL106326A0 publication Critical patent/IL106326A0/xx
Publication of IL106326A publication Critical patent/IL106326A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/635—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/50—Fusion polypeptide containing protease site
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/10011—Details dsDNA Bacteriophages
    • C12N2795/10211—Podoviridae
    • C12N2795/10222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL106326A 1992-07-15 1993-07-13 Analogs of parathyroid hormone, their production and pharmaceutical compositions containing them IL106326A (en)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
GB929215009A GB9215009D0 (en) 1992-07-15 1992-07-15 Organic compounds
GB929226415A GB9226415D0 (en) 1992-12-18 1992-12-18 Organic compounds
GB929226859A GB9226859D0 (en) 1992-12-23 1992-12-23 Organic compounds
GB929226861A GB9226861D0 (en) 1992-12-23 1992-12-23 Organic compounds
GB939301692A GB9301692D0 (en) 1993-01-28 1993-01-28 Organic compounds
GB939301691A GB9301691D0 (en) 1993-01-28 1993-01-28 Organic compounds
GB939307673A GB9307673D0 (en) 1993-04-14 1993-04-14 Organic compounds
GB939308033A GB9308033D0 (en) 1993-04-19 1993-04-19 Organic compounds

Publications (2)

Publication Number Publication Date
IL106326A0 IL106326A0 (en) 1994-04-12
IL106326A true IL106326A (en) 1997-09-30

Family

ID=27571302

Family Applications (1)

Application Number Title Priority Date Filing Date
IL106326A IL106326A (en) 1992-07-15 1993-07-13 Analogs of parathyroid hormone, their production and pharmaceutical compositions containing them

Country Status (25)

Country Link
US (2) US20050009147A1 (fr)
EP (1) EP0672057B1 (fr)
JP (1) JP3164463B2 (fr)
KR (1) KR100321651B1 (fr)
CN (1) CN1051769C (fr)
AT (1) AT408100B (fr)
AU (1) AU672790B2 (fr)
CA (1) CA2100423C (fr)
CH (1) CH688195A5 (fr)
CZ (1) CZ286889B6 (fr)
DE (2) DE4393381T1 (fr)
DK (1) DK0672057T3 (fr)
ES (1) ES2150948T3 (fr)
FI (1) FI113872B (fr)
GB (1) GB2269176B (fr)
GR (1) GR3035089T3 (fr)
HK (1) HK1004896A1 (fr)
HU (2) HUT70459A (fr)
IL (1) IL106326A (fr)
NO (1) NO319448B1 (fr)
NZ (1) NZ248137A (fr)
PT (1) PT672057E (fr)
SG (1) SG63625A1 (fr)
SK (1) SK283485B6 (fr)
WO (1) WO1994002510A2 (fr)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5814603A (en) * 1992-06-12 1998-09-29 Affymax Technologies N.V. Compounds with PTH activity
WO1995011697A1 (fr) * 1993-10-27 1995-05-04 Chugai Seiyaku Kabushiki Kaisha Accelerateur de guerison utilise en chondroplastie
US5955425A (en) * 1996-08-02 1999-09-21 National Research Council Of Canada Parathyroid hormone analogues for the treatment of osteoporosis
US6110892A (en) 1994-06-20 2000-08-29 National Research Council Of Canada Parathyroid hormone analogues for the treatment of osteoporosis
US5556940A (en) * 1994-06-20 1996-09-17 National Research Council Of Canada Parathyroid hormone analogues for the treatment of osteoporosis
CO4410206A1 (es) * 1994-07-28 1997-01-09 Sandoz Ag DERIVADOS DE PTH o PTHrP, SU PREPARACION Y COMPOSICIONES FARMACEUTICAS QUE LAS COMPRENDEN
US5747456A (en) * 1994-12-19 1998-05-05 Beth Israel Deaconess Medical Center Continuous low-dose administration of parathyroid hormone or its agonist
CA2178894A1 (fr) * 1995-06-15 1996-12-16 Tsunehiko Fukuda Derives de la parathormone et leur utilisation
US5955574A (en) * 1995-07-13 1999-09-21 Societe De Conseils De Recherches Et D'applications Scientifiques, S.A. Analogs of parathyroid hormone
US5723577A (en) * 1995-07-13 1998-03-03 Biomeasure Inc. Analogs of parathyroid hormone
US5969095A (en) * 1995-07-13 1999-10-19 Biomeasure, Inc. Analogs of parathyroid hormone
US7410948B2 (en) 1995-07-13 2008-08-12 Societe De Conseils De Recherches Et D'applications Scientifiques, Sas Analogs of parathyroid hormone
US6544949B1 (en) 1995-07-13 2003-04-08 Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S. Analogs of parathyroid hormone
GEP20033095B (en) * 1996-08-02 2003-10-27 Nat Res Council Canada Parathyroid Hormone Analogues for the Treatment of Osteoporosis
EP1352912A1 (fr) * 1996-08-02 2003-10-15 National Research Council Of Canada Analogues de l'hormone parathyroidienne pour le traitement de l'osteoporose
BR9808786A (pt) 1997-05-14 2000-07-11 Rhone Poulenc Rorer Pharma Composto peptìdio cìclico ou um seu sal ou pró-medicamento farmaceuticamente aceitáveis, composição farmacêutica, e, processos para tratar doenças associadas com a regulagem do cálcio em um paciente e para tratar a osteopenia ou a osteoporose em um mamìfero hospedeiro
AU8356198A (en) * 1997-07-22 1999-02-16 Chugai Seiyaku Kabushiki Kaisha Dental remedies containing pth
RU2224539C2 (ru) * 1997-09-09 2004-02-27 Ф.Хоффманн-Ля Рош Аг Заживление переломов с помощью аналогов пептида, подобного паратироидному гормону (ртнrр)
DE69938548T2 (de) 1998-05-05 2009-06-18 Beth Israel Deaconess Medical Center, Inc., Boston Pth2 rezeptor selektive verbindungen
JP4486256B2 (ja) 1998-10-22 2010-06-23 ザ・ジェネラル・ホスピタル・コーポレイション 副甲状腺ホルモン（ＰＴＨ）および副甲状腺ホルモン関連ペプチド（ＰＴＨｒＰ）の生物活性ペプチドおよびペプチド誘導体
DE69942035D1 (de) 1998-11-25 2010-04-01 Gen Hospital Corp Menschliches parathyroidhormon, modifikationen, herstellung und verwendung
WO2000040698A1 (fr) 1998-12-31 2000-07-13 The General Hospital Corporation Recepteur pth et test de criblage l'utilisant
AU2486800A (en) * 1998-12-31 2000-07-31 General Hospital Corporation, The Pth functional domain conjugate peptides, derivatives thereof and novel tetheredligand-receptor molecules
US7057012B1 (en) 1998-12-31 2006-06-06 The General Hospital Corporation PTH functional domain conjugate peptides, derivatives thereof and novel tethered ligand-receptor molecules
US20050272652A1 (en) * 1999-03-29 2005-12-08 Gault Victor A Peptide analogues of GIP for treatment of diabetes, insulin resistance and obesity
DE19916419B4 (de) * 1999-04-08 2005-06-16 Schering Ag Kombinationspräparat aus Vitamin-D-Metaboliten oder Vitamin-D-Analoga und einem Östrogenpartialagonisten zur Behandlung von Osteoporose
WO2001023521A2 (fr) 1999-09-29 2001-04-05 The General Hospital Corporation Derives polypeptidiques de l'hormone parathyroidienne (pth)
WO2003009804A2 (fr) 2001-07-23 2003-02-06 The General Hospital Corporation Analogues d'hormone parathyroide (pth) a contrainte conformationnelle
EP1531855A4 (fr) 2002-01-10 2009-07-22 Osteotrophin Llc Traitement des affections osseuses avec des medicaments anabolisants du squelette
GB0205693D0 (en) * 2002-03-09 2002-04-24 Astrazeneca Ab Chemical compounds
AU2003239869A1 (en) 2002-05-23 2003-12-12 Michael Holick Use of a parathyroid hormone peptide analogs for the treatment of vaginal atrophy
AU2002951372A0 (en) * 2002-09-13 2002-09-26 St Vincent's Institute Of Medical Research Parathyroid hormone-like polypeptides
WO2004093902A1 (fr) 2003-03-19 2004-11-04 The General Hospital Corporation Hormones parathyroidiennes contraintes de maniere conformationnelle avec des stabilisateurs en helice $g(a)
WO2005009358A2 (fr) 2003-07-17 2005-02-03 The General Hospital Corporation Analogues d'hormone parathyroide (pth) a conformation contrainte
US9046537B2 (en) 2003-09-22 2015-06-02 Enzo Biochem, Inc. Method for treating inflammation by administering a compound which binds LDL-receptor-related protein (LRP) ligand binding domain
AU2005244734A1 (en) 2004-05-13 2005-12-01 Alza Corporation Apparatus and method for transdermal delivery of parathyroid hormone agents
US9052324B2 (en) 2004-05-19 2015-06-09 Enzo Biochem, Inc. Compounds and assays for controlling Wnt activity
US8263545B2 (en) * 2005-02-11 2012-09-11 Amylin Pharmaceuticals, Inc. GIP analog and hybrid polypeptides with selectable properties
EP2390264A1 (fr) 2005-02-11 2011-11-30 Amylin Pharmaceuticals Inc. Analogues de GIP et polypeptides hybrides de GIP aux propriétés sélectionnables
AU2006289259A1 (en) * 2005-09-08 2007-03-15 Uutech Limited Analogs of gastric inhibitory polypeptide as a treatment for age related decreased pancreatic beta cell function
US20090170762A1 (en) * 2005-09-08 2009-07-02 Uutech Limited Treatment of Diabetes Related Obesity
WO2007059470A2 (fr) * 2005-11-10 2007-05-24 Board Of Control Of Michigan Technological University Parathormone de l'ours noir et procedes d'utilisation de la parathormone de l'ours noir
WO2008019062A2 (fr) * 2006-08-04 2008-02-14 The General Hospital Corporation Dérivés polypeptidiques de l'hormone parathyroïdienne (pth)
US8497240B2 (en) 2006-08-17 2013-07-30 Amylin Pharmaceuticals, Llc DPP-IV resistant GIP hybrid polypeptides with selectable properties
WO2008048784A1 (fr) 2006-10-13 2008-04-24 Eli Lilly And Company PHT pégylés en tant que modulateurs du récepteur PHT et leurs utilisations
US8568737B2 (en) 2007-08-01 2013-10-29 The General Hospital Corporation Screening methods using G-protein coupled receptors and related compositions
CN102245625A (zh) 2008-10-17 2011-11-16 威斯康星旧生研究基金会 制备有生物活性的α-β肽的方法
US8563513B2 (en) 2009-03-27 2013-10-22 Van Andel Research Institute Parathyroid hormone peptides and parathyroid hormone-related protein peptides and methods of use
JP2013512688A (ja) 2009-12-07 2013-04-18 ミシガン テクノロジカル ユニバーシティ クロクマの副甲状腺ホルモン及びクロクマの副甲状腺ホルモンを使用する方法
JP5941040B2 (ja) 2010-05-13 2016-06-29 ザ ジェネラル ホスピタル コーポレイション 副甲状腺ホルモン類似体およびその使用
US8609621B2 (en) 2010-11-15 2013-12-17 E I Du Pont De Nemours And Company Acid-cleavable linkers exhibiting altered rates of acid hydrolysis
US20140228293A1 (en) * 2011-03-01 2014-08-14 The General Hospital Corporation Parathyroid hormone analogs, compositions and uses thereof
US20170037086A1 (en) * 2014-04-09 2017-02-09 Aileron Therapeutics, Inc. Peptidomimetic macrocycles with pth activity
WO2020132269A1 (fr) 2018-12-20 2020-06-25 KSQ Therapeutics, Inc. Pyrazolopyrimidines substituées et purines substituées et leur utilisation en tant qu'inhibiteurs de protéase 1 de traitement spécifique de l'ubiquitine
KR20230098186A (ko) 2020-10-30 2023-07-03 케이에스큐 세러퓨틱스 인코포레이티드 치환된 피라졸로피리미딘의 고체 상태 형태 및 이의 용도
WO2023066881A1 (fr) 2021-10-18 2023-04-27 Astrazeneca Ab Inhibition de map3k15 pour le traitement et la prévention du diabète

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3886132A (en) * 1972-12-21 1975-05-27 Us Health Human parathyroid hormone
US4423037A (en) * 1982-05-13 1983-12-27 The General Hospital Corporation Inhibitors of peptide hormone action
FR2550204B1 (fr) * 1983-08-05 1987-11-13 Toyo Jozo Kk Derives peptidiques de (nle8,nle1b, tyr34)-h-pth
US4752585A (en) * 1985-12-17 1988-06-21 Cetus Corporation Oxidation-resistant muteins
US5420242A (en) * 1986-10-22 1995-05-30 Kaare M. Gautvik Production of human parathyroid hormone from microorganisms
US5001223A (en) * 1987-05-26 1991-03-19 Merck & Co., Inc. Parathyroid hormone antagonists with enhanced metabolic properties
EP0293158A3 (fr) * 1987-05-26 1990-05-09 Merck & Co. Inc. Antagonistes d'hormone parathyroide
US4771124A (en) * 1987-05-26 1988-09-13 Merck & Co., Inc. Parathyroid hormone antagonists with simplified synthetic methodology
DE3725320A1 (de) * 1987-07-30 1989-02-09 Biotechnolog Forschung Gmbh Expressionsvektoren und verfahren unter deren verwendung zur gewinnung von cro/ss-galaktosidase/pth-fusionsproteinen und von pth
US4968669A (en) * 1988-05-09 1990-11-06 Merck & Co., Inc. Parathyroid hormone antagonists
JPH03504201A (ja) * 1989-02-23 1991-09-19 ゲゼルシャフト・フュア・ビオテクノロギッシェ・フォルシュンク・ミット・ベシュレンクテル・ハフツング　（ゲー・ベー・エフ） Ｐｔｈ変種をコードするｄｎａ配列、ｐｔｈ変種、発現ベクター、細菌宿主、利用と治療用組成物
CA2040264A1 (fr) * 1990-04-12 1991-10-13 Tatsuhiko Kanmera Antagonistes de la parathormone
US5093233A (en) * 1990-04-25 1992-03-03 Merck & Co., Inc. Antagonists with position 13 modification
GB9020544D0 (en) * 1990-09-20 1990-10-31 Sandoz Ltd Improvements in or relating to organic compounds
JPH0532696A (ja) * 1990-09-28 1993-02-09 Takeda Chem Ind Ltd 副甲状腺ホルモン誘導体
AU9103791A (en) * 1990-12-21 1992-07-22 Allelix Biopharmaceuticals Inc. Oxidation resistant variants of parathyroid hormone
ES2087323T3 (es) * 1991-02-19 1996-07-16 Takeda Chemical Industries Ltd Metodo para producir peptidos exentos de cisteina.
US5317010A (en) * 1991-10-10 1994-05-31 Peter K. T. Pang Parathyroid hormone analogues substituted at AA 25, 26, 27, and use in osteoporosis treatment
US5434246A (en) * 1992-03-19 1995-07-18 Takeda Chemical Industries, Ltd. Parathyroid hormone derivatives
US5382658A (en) * 1992-04-03 1995-01-17 Allelix Biopharmaceuticals Inc. Stability-enhanced variants of parathyroid hormone
US5589452A (en) * 1992-07-14 1996-12-31 Syntex (U.S.A.) Inc. Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis

Also Published As

Publication number Publication date
FI950171A (fi) 1995-03-13
CN1099801A (zh) 1995-03-08
EP0672057A1 (fr) 1995-09-20
CA2100423C (fr) 2005-06-14
PT672057E (pt) 2001-02-28
US20080318838A1 (en) 2008-12-25
ES2150948T3 (es) 2000-12-16
NO950123D0 (no) 1995-01-12
NZ248137A (en) 1995-12-21
WO1994002510A2 (fr) 1994-02-03
HK1004896A1 (en) 1998-12-11
GB9314384D0 (en) 1993-08-25
WO1994002510A3 (fr) 1994-05-26
DK0672057T3 (da) 2000-12-27
ATA903993A (de) 2001-01-15
HUT70459A (en) 1995-10-30
FI113872B (fi) 2004-06-30
SK4395A3 (en) 1995-06-07
CH688195A5 (de) 1997-06-13
GB2269176A (en) 1994-02-02
CZ8895A3 (en) 1995-10-18
DE4393381B4 (de) 2008-07-17
GR3035089T3 (en) 2001-03-30
FI950171A0 (fi) 1995-01-13
CN1051769C (zh) 2000-04-26
AU4156693A (en) 1994-01-20
CA2100423A1 (fr) 1994-01-16
EP0672057B1 (fr) 2000-09-20
KR940005670A (ko) 1994-03-22
SG63625A1 (en) 1999-03-30
DE4393381T1 (de) 1995-04-27
SK283485B6 (sk) 2003-08-05
HU211856A9 (en) 1995-12-28
NO950123L (no) 1995-03-15
GB2269176B (en) 1997-01-08
HU9500115D0 (en) 1995-03-28
IL106326A0 (en) 1994-04-12
NO319448B1 (no) 2005-08-15
JP3164463B2 (ja) 2001-05-08
CZ286889B6 (en) 2000-07-12
AU672790B2 (en) 1996-10-17
AT408100B (de) 2001-08-27
US20050009147A1 (en) 2005-01-13
JPH06184198A (ja) 1994-07-05
KR100321651B1 (ko) 2002-05-13

Similar Documents

Publication Publication Date Title
IL106326A (en) Analogs of parathyroid hormone, their production and pharmaceutical compositions containing them
IL105283A0 (en) Stability-enhanced variants of parathyroid hormone,pharmaceutical compositions containing the same and methods for the preparation thereof
HUT47274A (en) Process for producing terciary hydroxy-alkyl-xantines and pharmaceutical compositions containing them as active components
IL78079A0 (en) Sulphonylaminoethyl compounds,their preparation and pharmaceutical compositions containing them
IL76591A0 (en) Pharmaceutical compositions containing ifn-ypsilon and processes for the preparation thereof
IL88670A0 (en) 2,5-diaryl-tetrahydrofurans and analogs thereof and pharmaceutical compositions containing them
ZA853729B (en) New aminotetralin derivatives,pharmaceutical compositions containing these compounds and processes for their preparation
IL102734A0 (en) Tissue-selective insulin analogs,their production and pharmaceutical compositions containing them
IL92054A0 (en) Spiro-isoquinoline-pyrrolidine tetrones and analogs thereof,their preparation and pharmaceutical compositions containing them
IL107653A0 (en) N,n-disubstituted arylcycloalkylamines their preparation and pharmaceutical compositions containing them
IL104999A0 (en) Substituted phenylacetamides,their preparation and pharmaceutical compositions containing them
PT83260A (en) Process for the preparation of spergualin telated compounds and of pharmaceutical compositions containing them
GB2167746B (en) A process for the preparation of isosilybin-free silibinin and pharmaceutical compositions containing it
IL85290A0 (en) Substituted 3,4-dihydro-2h-benzopyrans,processes for their preparation and pharmaceutical compositions containing same
PT81502A (en) Process for the preparation of cholecalciferol derivatives and of pharmaceutical compositions containing the same
ZA862141B (en) Substituted 1,8-naphthyridinones,processes for their preparation and pharmaceutical compositions containing them
IL72219A (en) Peptide from the calcitonin group,its production and pharmaceutical compositions containing it
IL75720A0 (en) Morpholinol compounds,their preparation and pharmaceutical compositions containing them
IL80820A0 (en) Imidazopyridazinealkenoic acid amides,processes and intermediate compounds for their preparation and pharmaceutical compositions containing them
DE3379657D1 (en) Dicyclic hexapeptides, processes for their preparation and pharmaceutical compositions containing them
IL78957A0 (en) 11-beta substituted steroids,their preparation and pharmaceutical compositions containing them
IL74264A0 (en) Preparation of calciferol derivatives,certain such novel compounds and pharmaceutical compositions containing them
PT83231A (en) Process for the preparation of gem-dihalo-1,8-diamino-4-aza-octanes and of pharmaceutical compositions containing the same
IL91864A0 (en) Pharmaceutical compositions containing 4-bitrophenyl-dihydropyridine amides,certain such novel compounds and their preparation
IL94645A0 (en) Preparation of n-oxo-tetrahydro-beta-carbolines,certain such novel compounds and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees